{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective from the specified list.", "method": "llm_batch", "batch_id": "batch_1_19856", "batch_size": 200, "batch_pos": 109, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language without high-potency verbs, metaphors, superlatives, intensifiers, or alert phrases.", "method": "llm_batch", "batch_id": "batch_2_15072", "batch_size": 200, "batch_pos": 90, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_8472", "batch_size": 200, "batch_pos": 26, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_6604", "batch_size": 200, "batch_pos": 23, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_9376", "batch_size": 200, "batch_pos": 20, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment quotes a source stating they 'can confirm we are in discussions' (a Q5 cue) but not a Q6 minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_8760", "batch_size": 200, "batch_pos": 182, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment states a fact (discussions) but contains no bare negation or explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_18348", "batch_size": 200, "batch_pos": 170, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "The segment quotes the company confirming 'we are in discussions with the U.S. government on advancing our pandemic flu candidate', indicating development of a future capability, without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_216", "batch_size": 200, "batch_pos": 131, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
